HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA-FTC Collaboration Relies On Joint Enforcement, Not Single Agency Acts

This article was originally published in The Tan Sheet

Executive Summary

A recent FDA warning letter that erroneously referenced Federal Trade Commission enforcement without FTC's approval did not mark the new milestone in the agencies' collaboration that some experts perceived.

You may also be interested in...



Enforcement In Brief

NAD refers supplement to FTC, FDA

FTC Raises Claim Substantiation Bar For Dietary Supplements In Settlements

The Federal Trade Commission tightens enforcement loopholes for dietary supplement advertisements in recent settlements by redefining substantiation requirements for some health claims and requiring FDA pre-approval for others

FTC Stakes New Territory, Joins FDA In Warning On H1N1 Claims

A warning letter sent jointly by FDA and the Federal Trade Commission takes a double-pronged approach toward cracking down on a supplement marketer's claims regarding the H1N1 flu virus

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134247

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel